English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Cystatin C is a more sensitive indicator of mild renal impairment and better estimates the glomerular filtration rate than serum creatinine [1]. Recently, cystatin C has been suggested to provide information beyond renal function. Several studies suggested that cystatin C is associated with obesity, atherosclerosis, insulin resistance, and hypertension [2,3]. Furthermore, in Western populations, elevated levels of serum cystatin C are associated with prediabetes or diabetes [4,5,6].In this article entitled  association of serum cystatin C with glycosylated hemoglobin in Korean adults, Sim et al. [7] evaluated the association between cystatin C and prevalence of diabetic conditions defined by glycosylated hemoglobin (HbA1c) levels in Korean adults. They described that higher levels of serum cystatin C are associated with an increased prevalence of diabetic conditions in Korean adults. Interestingly, the positive association between cystatin C and diabetic conditions was not significant in the multivariable models, and this result was consistent with a previous study [6]. Although the ethnic differences in this association are not fully understood, the association between cystatin C and diabetic conditions may be weaker in Asian populations compared to white populations. However, there are several issues that need to be discussed.First, Sabanayagam et al. [6] examined the association between serum cystatin C and prediabetes in non-obese United States adults. They examined 2,033 participants from the National Health and Nutrition Examination Survey 1999 to 2002, aged ≥20 years who were free of diabetes mellitus and chronic kidney disease. Compared to those with cystatin C in the lowest quartile (quartile 1), the multivariate odds ratio (OR) of prediabetes among those in the highest quartile (quartile 4) was 2.08 (95% confidence interval [CI], 1.09 to 3.97; P for trend=0.02). The interesting point was that an inverse association was observed between cystatin C and prediabetes in quartile 2 (OR, 0.58; 95% CI, 0.37 to 0.89). In subgroup analysis, this inverse association in quartile 2 was significant in men and other race-ethnicities. In this study, the relative risk of subjects in the group with the fourth serum cystatin C levels (fourth=1.0 mg/L) for the presence of diabetic conditions was significantly decreased compared to the lowest group (first u003c0.8 mg/L) in the multivariable model (OR, 0.61; 95% CI, 0.39 to 0.97; P=0.037). Furthermore, this inverse association was also significant in men (OR, 0.48; 95% CI, 0.26 to 0.88; P=0.019). These results are compatible with the aforementioned study [6] but the reason for inverse association remains unclear.Second, specific conditions such as severe anemia and diseases that change erythrocyte lifespan should be excluded. HbA1c has been proposed as a diagnostic tool to identify people with undiagnosed diabetes or those who are at risk of diabetes [8]. The HbA1c test is a very attractive test for the diagnosis of diabetes and prediabetes because it is easy, reproducible, and reflects the mean blood glucose levels over a period of time [8,9]. However, the HbA1c is affected not only by age and race but also by various diseases such as anemia, liver cirrhosis, and chronic kidney disease [10]. Analyzing the patients without diseases that can potentially affect HbA1c level would be more appropriate to evaluate the association between cystatin C and prevalence of diabetic conditions defined by HbA1c levels.

Letter: The Association of Serum Cystatin C with Glycosylated Hemoglobin in Korean Adults (Diabetes Metab J 2016;40:62-9)